Techno Medica Co., Ltd. (6678) Stock Price

Technomedica's primary business involves the research and development, manufacturing, sales, and export of clinical laboratory analyzers and medical devices. The company also manufactures and sells consumables used with these devices, as well as provides maintenance services. Products are sold both directly to domestic and international users and through sales distributors.

The company operates as a single business segment, with products classified into three categories. First is the blood collection tube preparation system. This automated system streamlines operations from patient check-in for blood and urine tests through blood collection tube preparation, reducing patient wait times and preventing specimen mix-ups.

Second is the specimen testing equipment. These devices measure specimens such as blood in medical facilities to assess patient health status. This category includes blood gas analyzers, electrolyte analyzers, and erythrocyte sedimentation rate measurement devices.

Third is consumables, which include labels and sensor cards used in blood collection tube preparation systems and specimen testing equipment. Maintenance services for these devices are also included. To ensure product quality, the company conducts quality inspections at two stages: during the manufacturing process and before shipment.

TechnoMedica provides distinctive products and services in the health and medical sectors, aiming to contribute to society. The company's growth strategy focuses on expanding product sales leveraging its technological capabilities domestically and internationally, as well as creating new business opportunities through new product development. In particular, the company aims to increase sales by improving reliability and quality in the domestic market.

TechnoMedica has formulated a new medium-term management plan starting in fiscal year 2023, promoting the strengthening of its business foundation and research and development investments. Under this plan, the company targets cumulative sales of 30.8 billion yen and operating profit of 4.5 billion yen over three years. Its basic policy is to enhance the reliability and quality of blood collection tube preparation devices and specimen testing equipment to meet customer expectations.

The medical device industry requires support for healthcare professionals. TechnoMedica is focusing on expanding its product lineup to contribute to operational efficiency in medical institutions and maintaining stable product supply. In particular, the company is advancing the development and sales expansion of blood collection tube preparation devices.

While addressing global challenges such as inflation and rising energy costs, TechnoMedica aims to contribute to solving social issues in the health and medical sectors. The company is pursuing a strategy to create corporate value through providing solutions across three product categories toward the realization of a sustainable society.